Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study
- PMID: 22348122
- PMCID: PMC3279412
- DOI: 10.1371/journal.pone.0031696
Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study
Abstract
Background: The aim of this study was to estimate healthcare resource utilization, work absenteeism and cost per patient with pandemic influenza (H1N1)2009, from its beginning to March 2010, in Spain. We also estimated the economic impact on healthcare services.
Methods and findings: Longitudinal, descriptive, multicenter study of in- and outpatients with confirmed diagnosis of influenza A (H1N1) in Spain. Temporal distribution of cases was comparable to that in Spain. Information of healthcare and social resources used from one week before admission (inpatient) or index-medical visit (outpatient) until recovery was gathered. Unit cost was imputed to utilization frequency for the monetary valuation of use. Mean cost per patient was calculated. A sensitivity analysis was conducted, and variables correlated with cost per patient were identified. Economic impact on the healthcare system was estimated using healthcare costs per patient and both, the reported number of confirmed and clinical cases in Spain. 172 inpatients and 224 outpatients were included. Less than 10% were over 65 years old and more than 50% had previous comorbidities. 12.8% of inpatients were admitted to the Intensive Care Unit. Mean length of hospital stay of patients not requiring critical care was 5 days (SD = 4.4). All working-inpatients and 91.7% working-outpatients went on sick leave. On average, work absenteeism was 30.5 days (SD = 20.7) for the first ones and 9 days (SD = 6.3) for the latest. Caregivers of 21.7% of inpatients and 8.5% of outpatients also had work absenteeism during 10.7 and 4.1 days on average respectively. Mean cost was €6,236/inpatient (CI95% = 1,384-14,623) and €940/outpatient (CI95% = 66-3,064). The healthcare economic burden of patients with confirmed influenza was €144,773,577 (IC95% 13,753,043-383,467,535). More than 86% of expenditures were a result of outpatients' utilization.
Conclusion: Cost per H1N1-patient did not defer much from seasonal influenza estimates. Hospitalizations and work absenteeism represented the highest cost per patient.
Conflict of interest statement
Figures




Similar articles
-
[Use of services and costs in patients with influenza (H1N1) 2009 in Spain: background and research protocol].Rev Esp Salud Publica. 2011 Jan-Feb;85(1):19-31. doi: 10.1590/S1135-57272011000100003. Rev Esp Salud Publica. 2011. PMID: 21750839 Spanish.
-
Economic burden and secondary complications of influenza-related hospitalization among adults in the US: a retrospective cohort study.J Med Econ. 2024 Jan-Dec;27(1):324-336. doi: 10.1080/13696998.2024.2314429. Epub 2024 Feb 22. J Med Econ. 2024. PMID: 38343288
-
Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave.BMC Public Health. 2010 Nov 24;10:724. doi: 10.1186/1471-2458-10-724. BMC Public Health. 2010. PMID: 21106057 Free PMC article.
-
The impact of influenza on working days lost: a review of the literature.Pharmacoeconomics. 2008;26(11):911-24. doi: 10.2165/00019053-200826110-00004. Pharmacoeconomics. 2008. PMID: 18850761 Review.
-
Impact of Influenza and Influenza-Like Illness on Work Productivity Outcomes: A Systematic Literature Review.Pharmacoeconomics. 2023 Mar;41(3):253-273. doi: 10.1007/s40273-022-01224-9. Epub 2022 Dec 14. Pharmacoeconomics. 2023. PMID: 36515814 Free PMC article.
Cited by
-
Clinical and economic burden of physician-diagnosed influenza in adults during the 2017/2018 epidemic season in Spain.BMC Public Health. 2022 Dec 17;22(1):2369. doi: 10.1186/s12889-022-14732-2. BMC Public Health. 2022. PMID: 36527015 Free PMC article.
-
A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks.Appl Health Econ Health Policy. 2021 Sep;19(5):673-697. doi: 10.1007/s40258-021-00659-z. Epub 2021 Jun 11. Appl Health Econ Health Policy. 2021. PMID: 34114184 Free PMC article.
-
Cost-of-illness comparison between clinical judgment and molecular point-of-care testing for influenza-like illness patients in Germany.NPJ Prim Care Respir Med. 2023 Jan 17;33(1):3. doi: 10.1038/s41533-022-00325-4. NPJ Prim Care Respir Med. 2023. PMID: 36650143 Free PMC article.
-
Disease burden of influenza in Spain: A five-season study (2015-2020).Hum Vaccin Immunother. 2025 Dec;21(1):2440206. doi: 10.1080/21645515.2024.2440206. Epub 2025 Jan 27. Hum Vaccin Immunother. 2025. PMID: 39869931 Free PMC article.
-
Excess influenza hospital admissions and costs due to the 2009 H1N1 pandemic in England.Health Econ. 2019 Feb;28(2):175-188. doi: 10.1002/hec.3834. Epub 2018 Oct 18. Health Econ. 2019. PMID: 30338588 Free PMC article.
References
-
- Ampofo K, Gesteland PH, Bender J, Mills M, Daly J, et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics. 2006;118:2409–2417. - PubMed
-
- Esposito S, Cantarutti L, Molteni CG, Daleno C, Scala A, et al. Clinical manifestations and socio-economic impact of influenza among healthy children in the community. J Infect. 2011;62:379–387. - PubMed
-
- Neuzil KM, Maynard C, Griffin MR, Heagerty P. Winter respiratory viruses and health care use: a population-based study in the northwest United States. Clin Infect Dis. 2003;37:201–207. - PubMed
-
- Sierra Moros MJ, Vazquez TM, Santa-Olalla PP, Limia SA, Cortes GM, et al. [Epidemiological surveillance activities during the 2009 influenza pandemic in Spain: lessons learnt one year after]. Rev Esp Salud Publica. 2010;84:463–479. - PubMed